<DOC>
	<DOCNO>NCT01494558</DOCNO>
	<brief_summary>Cisplatin-based combination chemotherapy give concurrently radiotherapy standard care patient inoperable stage III NSCLC . The common chemotherapeutic agent use concurrently radiotherapy vinorelbine , vinblastine , etoposide conjunction cisplatin weekly paclitaxel carboplatin . No randomized phase III trial concurrent chemoradiotherapy show superiority one chemotherapy regimen another . The clinical trial compare radiotherapy concurrently PE ( etoposide cisplatin ) PC ( paclitaxel carbplatin ) local advance NSCLC ( stage IIIA/IIIB ) . It randomize , multicenter , open label phase III clinical trial . All patient receive conformal radiotherapy intensity modulate radiotherapy conventional fraction . The chemotherapy regimens PE ( etoposide 50mg/m2 d1-5 , 29-33 cisplatin 50mg/m2 d1,8,29 36 29-33 ) PC ( paclitaxel 45mg/m2 weekly 1hour carbplatin AUC =2mg/mL/min 30min weekly ) . The primary purpose evaluate objective response rate , complication , progression-free survival , overall survival . The second purpose evaluate quality life cost .</brief_summary>
	<brief_title>Study Etoposide , Cisplatin , Radiotherapy Versus Paclitaxel , Carboplatin Radiotherapy Treat Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>1 . Inoperable stage IIIA/IIIB NSCLC prove pathology cytology 2 . Age 18 75 , ECOG â‰¤ 2 , lose weight &lt; 10 % 6 month 3 . No serious disease important organ 4 . Chest CT recently 4 week 5 . No tumor disease except stage I cervical cancer cutaneous basal cell carcinoma 6 . Sign consent 7 . Measurable lesion 1 . Pretreatment radiotherapy chemotherapy 2 . Pregnant lactation woman 3 . Serious disease ( include uncontrolled diabetes infection ) important organ 4 . Psychopath 5 . Join clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Overall survival</keyword>
</DOC>